Publication date: November 2026 Source: The Lancet Oncology, Volume 27, Issue 11 Author(s): Christopher M Booth, Carolyn Taylor, Christopher G C A Jackson, Michelle Tregear, Manju Sengar, Brooke E Wilson, Ian F Tannock, Bishal Gyawali, Scott R Berry, Haydeé Verduzco-Aguirre, Craig Leroux, Richard Sullivan
The unfulfilled promise of effective cancer medicines priced beyond reach. // The Lancet Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S1470204526005334?dgcid=rss_sd_all
The unfulfilled promise of effective cancer medicines priced beyond reach. The Lancet Oncology. https://www.sciencedirect.com/science/article/pii/S1470204526005334?dgcid=rss_sd_all
“The unfulfilled promise of effective cancer medicines priced beyond reach.” The Lancet Oncology.
@article{article90965,
title = {The unfulfilled promise of effective cancer medicines priced beyond reach},
journal = {The Lancet Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S1470204526005334?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment